PILOT - Pulmonary Education for Health Care Providers

Pulmonology

Search

Saved Activities

0 Activities

0 Activities

Filter Content

PILOTforPulmonary.org

PILOT provides comprehensive continuing medical education, supporting the diagnosis and management patients for various pulmonary diseases.

Page 2 of 4

Results 76 - 150 of 230

Interim Analysis of SENSCIS-ON TRIAL for SSc-ILD Patients Treated with Nintedanib

Monitoring for Changes in Disease Course and Comorbidities in SSc ILD

Utilizing ACIP's Updated Pneumococcal Recommendations - Rapid Recap

PILOTforPulmonary 2019: Data, Insights & Practice

Managing the Whole Patient with COPD: An Animated Video Series

My COPD Action Plan

Expert Recommendations for COPD

Surgical and Minimally Invasive Procedures that Might Benefit COPD Patients

COPD: Fixed Dose Combinations

COPD: Proper Inhaler Use

Clinical Pearls from New Orleans 2019

Inhaled NO in Patients at Risk for Pulmonary Hypertension

Nintedanib for Patients with Systemic Sclerosis-Related Interstitial Lung Disease

Considerations for Geriatric ILD Patients

Pirfenidone in Patients with Unclassifiable Interstitial Lung Disease

Emerging Diagnostic Approaches to Patients with ILD

Goals of Care Across the Disease Continuum in IPF

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

Current Perspective on Antifibrotic Therapy for Patients with IPF

Pulmonologists as the Gatekeepers of Precision Medicine

Interstitial Pneumonia with Autoimmune Features (IPAF)

How to Identify & Manage Patients with Progressive-Fibrosing ILD

Acute Exacerbations of IPF

Personalized Medicine for Improving Asthma Care: An Animated Video Series

9815-developments

New Developments in Pulmonary Diseases: Optimizing Patient Outcomes

9815-palliative slides

Palliative Medicine in Pulmonology

Patient Education, Adherence, Inhaler Technique, and Pulmonary Rehabilitation

Dyspnea and Disease are Progressing: What to Do?

A Closer Look at ILD, Sarcoidosis, and CTEPH

New Developments in Pulmonary Diseases: Optimizing Patient Outcomes

Discussions with Patients to Optimize Asthma Control

9916-0004_treatment

Who Should be Targeted For Treatment With Biologic Therapy?

9916-0003_endotypes

Endotypes and Phenotypes in Asthma

Mechanisms of Action of Biologic Therapies for Severe Asthma

Approved Medications for the Treatment of Severe Asthma

9907-0006_shared

Engage Your Patients in Shared Decision-Making

9907-0005_cardio

Is It IPF or Cardiovascular Disease?

Interstitial Pneumonia with Autoimmune Features

9907-0003_pf-ild

How to Identify Progressive Fibrosing ILD

When Is It a Connective Tissue Disease?

9907-0001_guidelines

How to Use IPF Guidelines to Make a Diagnosis

Advanced Care Planning and Palliative Care Models for Patients with IPF

Dyspnea Assessment in Patients with IPF

Which Patients with IPF Should be on Antifibrotics?

The Impact of Anticoagulation Use on IPF Patient Outcomes

Patient-Centered Outcomes for Patients with IPF: Activity Monitoring

Connective Tissue Disease-Related ILD is Now in the Limelight

Biomarkers in IPF and Other ILDs

9840-glassberg2

Evaluation and Diagnosis of IPF

9840-glassberg1

Initial Treatment Decisions of IPF

What if President Calvin Coolidge Was Your Asthma Patient?

Optimizing Management of IPF

New_Concepts_in_the_Pathobiology_of_Asthma_264x150

New Concepts in the Pathobiology of Asthma

What are the Most Exciting Things Happening in Pulmonary Disease?

When Is a Cough Not Just a Cough?

Diagnosing ILDs Such as IPF and More

Beyond the Basics: Complex ILD Cases

PowerPoint Slides: Achieving Better Control of Severe Asthma

How Would You Manage President Theodore Roosevelt’s Asthma Today?

Eugene’s U(I)P-Hill Battle

Is Mary’s PAH Making You Dizzy?

Jeff’s COPD is No Smoke!

Clearing the Air on Chuck’s Asthma

Shedding Light on Jane’s ILD Diagnosis

9815-palliative

When Should You Consider Palliative Care in the Patient Journey?

What is Your Treatment Recommendation for Sandra’s CTEPH?

Tracy Has Chest Palpitations and Cough: What Does Her Imaging Tell Us?

New Tools to Improve the Diagnosis of IPF vs Other ILDs

New Research on Therapies for Patients with Pulmonary Fibrosis

The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD

2019 Summer Pulmonary Updates: The Experts Weigh In

U.S. Presidents with Severe Asthma: Endotypes and Precision Medicine

Reporting HRCT Findings for ILD from a Multidisciplinary Team

A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story

How Pulmonary Arterial Hypertension Has Changed Iain’s Life

Page 2 of 4